Videos by Category
Breast Cancer
Dr. Wassim Mchayleh on ASCENT-03: Evaluating Sacituzumab Govitecan in HR+/HER2- Metastatic Breast Cancer
From Podium To Practice - Breast Cancer ESMO Part 1 In this overview, Dr. Wassim Mchayleh breaks down the ASCENT-03 trial, highlighting the rationale for...
Dr. Wassim Mchayleh on TROPION-Breast02: Evaluating Dato-DxD in Metastatic Breast Cancer
From Podium To Practice - Breast Cancer ESMO Part 2 In this segment, Dr. Wassim Mchayleh reviews the design and objectives of TROPION-Breast02, highlighting how...
Dr. Wassim Mchayleh on VIKTORIA-1: Gedatolisib Combinations in HR+/HER2- Metastatic Breast Cancer
From Podium To Practice - Breast Cancer ESMO Part 3 In this overview, Dr. Wassim Mchayleh explains the design and significance of VIKTORIA-1, a key...
Dr. Wassim Mchayleh on evERA: Exploring Elacestrant Combinations in ER+/HER2– Metastatic Breast Cancer
From Podium To Practice - Breast Cancer ESMO Part 4 In this overview, Dr. Wassim Mchayleh breaks down the evERA trial, which evaluates elacestrant-based combination...
Dr. Sara Tolaney & Dr. Wassim Mchayleh on Trial Design & Patient Populations in ASCENT-03 and TROPION-Breast02
From Podium To Practice - Breast Cancer ESMO Part 5 In this discussion, Dr. Wassim Mchayleh of AdventHealth introduces Dr. Sara Tolaney of Dana-Farber Cancer...
Interpreting Efficacy & Ethical Design: Drs. Tolaney and Mchayleh on ORR, PFS, OS & Crossover Strategy
From Podium To Practice - Breast Cancer ESMO Part 6 In this discussion, Dr. Wassim Mchayleh and Dr. Sara Tolaney dissect the efficacy signals from...
Head & Neck
Q&A with Dr. Greg Randolph: How Neural Monitoring Is Changing Thyroid Cancer Surgery
In this Q&A, Dr. Greg Randolph discusses the growing role of neural monitoring in managing advanced thyroid cancer. He describes how nerve mapping before visualization,...
Real-World Risks & Future Tech in Thyroid Cancer Surgery with Dr. Greg Randolph
In this video, Dr. Greg Randolph of Harvard Medical School discusses real-world considerations for neoadjuvant therapy in advanced thyroid cancer, emphasizing the differences between controlled...
Neoadjuvant Therapy in Advanced Thyroid Cancer: Surgical Impact & Evolving Challenges
In this video, Dr. Greg Randolph of Harvard Medical School explains how modern neoadjuvant therapies—including lenvatinib and targeted agents for RET-altered and anaplastic thyroid cancers—are...